Oto-obong Collins, Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 3932 Highway 90 W, Avondale, LA 70094 Phone: 504-436-2223 |
News Archive
Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.
Cardiologists increasingly use non-invasive methods to treat patients with diseased arteries that previously required open-heart surgery.
Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone's influenza monoclonal antibody program. The collaboration utilizes Theraclone's I-STARâ„¢ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.
Administering a substance found in the cannabis plant can help the body's natural protective system alleviate an allergic skin disease (allergic contact dermatitis), an international group of researchers from Germany, Israel, Italy, Switzerland and the U.S. has found.
Dr. Betsy McCaughey, Founder/ Chairman of the Committee to Reduce Infection Deaths (RID) said that "the 2009 New York State Department of Health Hospital Acquired Infections Report (released 9/1/2010) shows that mandatory disclosure saves lives by making hospitals work harder to prevent infections. Statewide rates decreased for nearly every type of infection measured. None increased."
› Verified 4 days ago